Frequencies of clinical and utility characteristics
| Characteristic | No (n=186) |
|---|---|
| Vision in affected eye | |
| 6/9 to 6/15 | 72 (32.6%) |
| 6/18 to 6/30 | 67 (30.3%) |
| 6/60 to 6/120 | 39 (17.6%) |
| CF to NLP | 43 (19.5%) |
| Vision in unaffected eye | |
| 6/7.5 or better | 68 (30.8%) |
| 6/9 to 6/15 | 99 (44.8%) |
| 6/18 to 6/30 | 33 (14.9%) |
| 6/60 to 6/120 | 18 (8.1%) |
| CF to NLP | 3 (1.4%) |
| Duration of visual loss | |
| 0 to1 year | 49 (22.2%) |
| 1.01 to 5 years | 100 (45.2%) |
| 5.01 to 10 years | 40 (18.1%) |
| More than 10 years | 32 (14.5%) |
| Years expected to live | |
| 0 to 5 years | 48 (21.7%) |
| 5.01 to 10 years | 60 (27.1%) |
| 10.01 to 20 years | 64 (29.0%) |
| More than 20 years | 49 (22.2%) |
| Comorbid diseases (no) | |
| 0 | 57 (25.8%) |
| 1 | 74 (33.5%) |
| 2 | 54 (24.4%) |
| 3 or more | 36 (16.3%) |